Streetbeat News

Earnings

MBUU

Malibu Boats (NASDAQ:MBUU) is expected to release its quarterly earnings report on January 30, 2024. Analysts predict an EPS of $0.48. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Malibu Boats has had mixed earnings performance, with share price reactions varying post-earnings release. The stock is currently trading at $50.0, down 16.31% over the last 52 weeks. Shareholders are likely concerned as they await the upcoming earnings report.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:01 pm

MDC

M.D.C. Holdings (NYSE:MDC) is expected to release its quarterly earnings report on January 30, 2024. Analysts predict an EPS of $1.49. Investors will be looking for an earnings beat and positive guidance for future growth. Historically, MDC's stock price has shown mixed reactions to earnings reports, with minor fluctuations regardless of beats or misses. Over the past year, MDC shares have increased by 65.97%, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:01 pm

PII

Polaris (NYSE:PII) is expected to release its quarterly earnings report on January 30, 2024, with an estimated EPS of $2.58. Investors are looking for an earnings beat and positive guidance for future growth. Polaris's stock performance has been negative over the past year, with a 20.16% decline. Historical data shows mixed reactions to past earnings reports, with both increases and decreases in stock price following announcements.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:01 pm

HOPE

Hope Bancorp (NASDAQ:HOPE) is expected to release its quarterly earnings report on January 30, 2024, with an estimated EPS of $0.21. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has reacted negatively to missed EPS estimates. Shares are currently trading at $11.83, down 7.95% over the last 52 weeks. The upcoming earnings report could influence the stock's performance.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:01 pm

UMBF

UMB Financial (NASDAQ:UMBF) is expected to release its quarterly earnings report on January 30, 2024. Analysts predict an EPS of $1.76. Investors are looking for an earnings beat and positive guidance for the next quarter. UMBF's past earnings performance shows a consistent history of beating EPS estimates, which has generally led to share price increases the following day. The stock is currently trading at $82.29, with a 52-week decrease of 8.75%. Shareholders are likely concerned as they await the earnings report.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:01 pm

GEN

Gen Digital (NASDAQ:GEN) has been reviewed by 4 analysts over the last three months, with a mix of bullish and indifferent sentiments. The average 12-month price target for GEN is $25.75, up 7.29% from the previous $24.00. Analysts from Morgan Stanley, B of A Securities, and RBC Capital have raised their price targets, reflecting a positive outlook on the company's performance. Gen Digital, known for its cybersecurity products like Norton, Avast, and LifeLock, has shown strong revenue growth and net margin but faces challenges with its high debt-to-equity ratio and below-average ROE.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

MANH

Manhattan Associates (NASDAQ:MANH) is expected to release its quarterly earnings report on January 30, 2024. Analysts predict an EPS of $0.80. Investors are looking for an earnings beat and positive guidance for future growth. Historically, MANH has surpassed EPS estimates, resulting in varied stock price reactions. Shares are currently trading at $219.76, with a 71.37% increase over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

CAC

Camden National (NASDAQ:CAC) is scheduled to release its quarterly earnings report on January 30, 2024. Analysts predict an EPS of $0.79. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, Camden National's stock price has been sensitive to earnings performance and guidance. Last quarter, the company missed EPS estimates by $0.08, resulting in a 0.96% share price drop the following day. Over the past year, shares have declined by 11.72%.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

AMGN

Amgen (NASDAQ:AMGN) has received mixed ratings from 11 analysts, with an average 12-month price target of $291.91, indicating a 5.6% increase from the previous target. Recent actions include ratings adjustments and price target changes by analysts from UBS, Daiwa Capital, BMO Capital, RBC Capital, Truist Securities, Deutsche Bank, and Morgan Stanley. Amgen's financials show a market cap above industry average, a 3.77% revenue growth, a high net margin of 25.06%, an ROE of 23.97%, and an ROA of 1.91%, but a high debt-to-equity ratio of 7.9. The company's portfolio includes drugs like Epogen, Aranesp, Neupogen, Neulasta, Enbrel, Otezla, Vectibix, Prolia/Xgeva, Evenity, Repatha, Aimovig, Lumakras, Tezspire, and Kyprolis from the Onyx acquisition. The recent Horizon acquisition adds drugs for rare diseases, including Tepezza.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:00 pm

PWOD

Penns Woods Bancorp reported an adjusted EPS of $0.77, an increase from the previous year's $0.71, indicating improved profitability.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 4:17 pm